Given the elevated circulating renin level in Eln+/− mice and about half of WS patients, it would be of interest to investigate the impact of ROS-limitating agents like apocynin and tempol on the contraction of the ascending aorta in response to angiotensin II. The gene discussed is ELN; the disease is Werner syndrome.